Molecular Epidemiological Study of Pyrazinamide-Resistance in Clinical Isolates of Mycobacterium tuberculosis from South India

Pyrazinamide (PZA) has been in use for almost 50 years as a first-line drug for short-course chemotherapy against Mycobacterium tuberculosis. In this study, PCR mediated automated DNA sequencing is used to check the prevalence of PZA resistance among treatment failure cases of pulmonary tuberculosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Muthaiah, Muthuraj, Jagadeesan, Sridharan, Ayalusamy, Nisha, Sreenivasan, Manupriya, Prabhu, Sambamurthy Sangamesvara, Muthuraj, Usharani, Senthilkumar, Kamatchiyammal, Veerappan, Saroja
Formato: Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2010
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920559/
https://www.ncbi.nlm.nih.gov/pubmed/20717529
http://dx.doi.org/10.3390/ijms11072670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920559/
https://www.ncbi.nlm.nih.gov/pubmed/20717529
http://dx.doi.org/10.3390/ijms11072670

Ejemplares similares